Evofem Biosciences, Inc.
EVFM
$0.0099
$0.00044.21%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -110.31% | -106.13% | -116.72% | -116.97% | -13.98% |
| Total Depreciation and Amortization | 544.38% | 540.38% | 53.25% | -39.01% | -82.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 97.55% | 92.64% | 105.03% | 97.40% | 33.74% |
| Change in Net Operating Assets | -73.37% | -66.26% | -81.66% | 52.34% | 6.34% |
| Cash from Operations | -47.13% | 11.70% | 56.68% | 89.26% | 87.86% |
| Capital Expenditure | 85.71% | 100.00% | -250.00% | 64.10% | 87.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4,285.71% | -3,980.00% | -14,125.00% | -1,241.03% | 87.16% |
| Total Debt Issued | -27.98% | -90.08% | -92.96% | -88.54% | 7.17% |
| Total Debt Repaid | 35.18% | 20.54% | 32.24% | 33.10% | -- |
| Issuance of Common Stock | 3,746.15% | 2,083.41% | 1,624.14% | -33.33% | -97.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | -- | -- | 391.55% |
| Cash from Financing | 62.78% | 45.69% | -3.37% | -58.19% | -53.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 149.70% | 103.84% | 103.31% | 100.26% |